美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Invesco Dorsey Wright Healthcare Momentum ETF

60.51

-1.1009-1.79%

成交量：3.13萬

成交額：189.84萬

市值：2.83億

市盈率：19.79

高：61.59

開：61.59

低：60.44

收：61.61

52周最高：64.10

52周最低：39.36

股本：467.00萬

流通股本：467.00萬

量比：3.48

換手率：0.67%

股息：1.53

股息率：2.53%

每股收益(TTM):3.06

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

【券商聚焦】中信建投：醫療器械板塊業績有望逐步改善

深港攜手拓全球藥械市場，2026深圳國際高性能醫療器械展舉行

Revolution Medicines獲摩根士丹利首次覆蓋，給予「增持」評級，目標價255美元

透景生命(300642.SZ)控股子公司申報醫療器械註冊獲得受理

Stifel上調Revolution Medicines目標價至230美元

賽諾醫療：關於參加上海證券交易所科創板2026年半年度醫療器械及醫療設備行業集體業績説明會的公告

BUZZ——美國股市動態-Sigma Lithium、Shake Shack、諾華

Roivant公司實驗性肺部疾病藥物在中期研究中達到預期目標

實驗性肺病藥物中期研究達主要終點 Roivant Sciences股價盤前飆升21.1%

Roivant公布Mosliciguat治療間質性肺病相關肺動脈高壓（Ph-Ild）的Phocus研究積極結果，並披露正在進行的Phrontier III期試驗

邁普醫學：可吸收止血流體明膠作為第三類醫療器械進入臨床試驗

中信建投：醫療器械業績持續改善醫療服務收入平穩增長

三諾生物：取得醫療器械註冊證及註冊變更文件

安圖生物：公司及子公司獲得四項醫療器械註冊證

麥科田（2041.HK）登陸港交所，平台型醫療器械龍頭起航

山東省寧陽縣市場監管局開展醫療器械專項現場檢查

中国质量新闻网

又一家醫療器械企業登陸港股，麥科田(02041)「含金量」幾何？

高瓴重倉的醫療器械公司，IPO首日開盤跌超30%

海南出台醫療器械委託生產監管新政

格式塔創始人彭雷：三到五年內，腦機接口本質上是嚴肅的醫療器械

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/PTH/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","market":"US","secType":"STK","nameCN":"Invesco Dorsey Wright Healthcare Momentum ETF","latestPrice":60.51,"timestamp":1789486953017,"preClose":61.6109,"halted":0,"volume":31272,"delay":0,"changeRate":-0.017868591434307936,"floatShares":4670000,"shares":4670000,"eps":3.057033,"marketStatus":"交易中","change":-1.1009,"latestTime":"09-15 11:43:18 EDT","open":61.585,"high":61.585,"low":60.44,"amount":1898352.6875999998,"amplitude":0.018584,"askPrice":60.7,"askSize":300,"bidPrice":60.59,"bidSize":100,"shortable":3,"etf":1,"ttmEps":3.057033,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":61.6109,"sharesOutstanding":2480000,"nav":60.75567,"aum":283728978.9,"dividendRate":0.025252,"bidAskSpread":0.001903,"postHourTrading":{"tag":"盘后","latestPrice":61.66,"preClose":61.6109,"latestTime":"19:30 EDT","volume":13,"amount":800.5754,"timestamp":1789428602402,"change":0.0491,"changeRate":0.000797,"amplitude":0},"volumeRatio":3.478921,"impliedVol":0.1559,"impliedVolPercentile":0.757},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","floatShares":4670000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":3.478921,"shares":4670000,"dividePrice":1.528,"high":61.585,"amplitude":0.018584,"preClose":61.6109,"low":60.44,"week52Low":39.36,"pbRate":"--","week52High":64.1,"institutionHeld":0,"latestPrice":60.51,"committee":-0.5,"eps":3.057033,"divideRate":0.025252,"volume":31272,"delay":0,"ttmEps":3.057033,"open":61.585,"prevYearClose":49.701,"prevWeekClose":60.7692,"prevMonthClose":60.7941,"prevQuarterClose":59.76,"fiveDayClose":61.7173,"twentyDayClose":60.8616,"sixtyDayClose":52.9818},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PTH","amount":1.52645,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-06-24","symbol":"PTH","amount":0.02545,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"market":"US","date":"2023-07-17","symbol":"PTH","defaultRemindTime":1689600600000,"type":"split","dateTimestamp":1689566400000,"forFactor":1,"toFactor":3,"ratio":0.3333333333333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTH\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-24","recordDate":"2024-06-24","paymentDate":"2024-06-28","value":0.02545,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-26","value":1.52645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTH\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666127155","title":"【券商聚焦】中信建投：醫療器械板塊業績有望逐步改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2666127155","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666127155?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 09:18","pubTimestamp":1789089493,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指，医疗器械板块Q2收入延续增长趋势，单季度利润增速四年来首次转正。该机构认为，随着集采影响逐步出清叠加创新驱动和海外业务加速的双重助力，医疗器械板块业绩有望逐步改善。尽管季度业绩增速可能有所波动，Q3能否相比Q2加速尚不确定，但大趋势来看，26和27年年度业绩持续改善的确定性较强。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991348","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066","09996","BK1617","BK1591","BK1583","01302","HART","BK1161","LNGR","BK1189","LU0287142896.SGD","02252","BK1571","RSPH","BK1615","BK1100","02190","02235","06826","BK1247","GDOC","BK1585","601066","BK1589","BK1600","LGHT","BK1587","BK1515","IEIH","PTH","AGNG","BK1501","00241","BK1610","BK0276","KCE","LU0173614495.USD","HK0000165453.HKD","BK1584","00853","MDEV","MEDX","BK1142","BK1222","BK1502","BK1593","159883","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666983512","title":"深港攜手拓全球藥械市場，2026深圳國際高性能醫療器械展舉行","url":"https://stock-news.laohu8.com/highlight/detail?id=2666983512","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666983512?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 09:10","pubTimestamp":1789089045,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LGHT","PTH","RSPH","BK1583","BK1507","BK1185","LU0067412154.USD","BK1582","GDOC","HART","MDEV","MEDX","IEIH","00152","BK1100","LU1152091754.HKD","159883","LU1008478684.HKD","09996","LNGR","BK1574","SG9999003461.SGD","LU0880133367.SGD","AGNG","LU1152091168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186962882","title":"Revolution Medicines獲摩根士丹利首次覆蓋，給予「增持」評級，目標價255美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1186962882","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186962882?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 18:10","pubTimestamp":1789035009,"startTime":"0","endTime":"0","summary":"摩根士丹利近日宣布首次覆盖生物制药公司Revolution Medicines, Inc.，并给予其“增持”评级。该机构将目标股价设定为每股255美元。这一举措标志着华尔街主要投行对这家专注于研发创新疗法的企业前景持乐观态度。值得注意的是，摩根士丹利的这一评级和价格目标，为投资者提供了新的参考坐标。此前，市场对Revolution Medicines的关注度持续攀升，尤其在肿瘤治疗领域，其管线布局备受瞩目。此次覆盖报告的出炉，或将在短期内影响该股的市场情绪与交易动态。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE0009354923.USD","IE0002141913.USD","RVMD","BBH","IE0009355771.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","PTH","IDNA","IE00B2B36J28.USD","LU0320765992.SGD","IE00BJT1NW94.SGD","LU0109394709.USD","CANC","IE00BFTCPJ56.SGD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666755282","title":"透景生命(300642.SZ)控股子公司申報醫療器械註冊獲得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2666755282","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666755282?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 11:50","pubTimestamp":1789012238,"startTime":"0","endTime":"0","summary":"智通财经APP讯，透景生命(300642.SZ)发布公告，公司控股子公司上海脉示生物技术有限公司申报的医疗器械注册申请于近日获得了上海市药品监督管理局的受理，产品名称：四项抗癫痫药物浓度测定试剂盒(液相色谱串联质谱法)。该产品用于检测人体血清样本中的丙戊酸、奥卡西平代谢物(10,11-二氢-10-羟基卡马西平)、托吡酯、左乙拉西坦浓度。临床上用于丙戊酸、奥卡西平代谢物(10,11-二氢-10-羟基卡马西平)、托吡酯、左乙拉西坦血药浓度的监测。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494298.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0042","IEIH","RSPH","HART","BK1583","159883","BK1100","300642","GDOC","AGNG","PTH","BK1574","MDEV","BK0239","LNGR","BK0046","LGHT","09996","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666554138","title":"Stifel上調Revolution Medicines目標價至230美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666554138","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666554138?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 11:17","pubTimestamp":1789010271,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE0009355771.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","IE00B2B36J28.USD","PTH","IDNA","LU0889565916.HKD","IE00BJT1NW94.SGD","UUP","BBH","IE0009354923.USD","LU0109394709.USD","BK4139","RVMD","CANC","IE0002141913.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","UDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666582190","title":"賽諾醫療：關於參加上海證券交易所科創板2026年半年度醫療器械及醫療設備行業集體業績説明會的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2666582190","media":"同花顺","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666582190?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 18:39","pubTimestamp":1788950340,"startTime":"0","endTime":"0","summary":"    证券日报网讯9月9日，赛诺医疗发布公告称，公司计划于2026年9月17日15：00-17：00参加上海证券交易所组织的科创板2026年半年度医疗器械及医疗设备行业集体业绩说明 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260909/c679749361.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260909/c679749361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK1574","IHI","MDEV","BK4588","BK1100","AGNG","BK0251","688108","KSTR","HART","MEDX","09996","BK4585","LNGR","PTH","XHE","RSPH","BK1583","159883","GDOC","LGHT","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375206","title":"BUZZ——美國股市動態-Sigma Lithium、Shake Shack、諾華","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375206","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665375206?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:58","pubTimestamp":1788875887,"startTime":"0","endTime":"0","summary":"BUZZ——美国股市动态-Sigma Lithium、Shake Shack、诺华工作区中用于查询单只股票行情的搜索字符串：STXBZ《今日展望》通讯：https://refini.tv/3LI4BU7《晨间新闻简报》：https://refini.tv/3dKUyB8路透9月8日-周二开盘时，华尔街主要股指涨跌不一，中东地区新一轮冲突推动油价升至7月下旬以来的最高水平，而市场正在等待本周晚些时候","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4S45014M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN","LU1548497426.USD","BK4566","IE00B66KJ199.SGD","LU0345769631.USD","BK4131","BE","LU1861559042.SGD","UPGR","BSX","IE00BBT3K403.USD","IONC","IONS","LU0868494617.USD","LU2264538146.SGD","PBE","LU2357125470.USD","BK4504","LU2357305700.SGD","LU0306806265.USD","LU0058720904.USD","LU0128526141.USD","FRNW","LU0138981039.USD","IE00BJT1NW94.SGD","LU1066053197.SGD","LU1093756168.USD","LU1366192091.USD","LU0320765992.SGD","LU2491050071.SGD","LU0070302665.USD","LU0187121727.USD","ICLN","IE000M9KFDE8.USD","BK4556","BK4179","BEG","LU0433182093.SGD","IE00B3T34201.USD","LU1023059063.AUD","SHAK","LU0456855351.SGD","BK4567","SMOG","LU0122379950.USD","BK4209","LU1989764748.USD","LU2491049909.HKD","XES","IE00BLSP4239.USD","EGGY","CTEC","LU1571399168.USD","LU1066051498.USD","LU2543165471.USD","BEC","BK4120","LU0321505439.SGD","LU0823414478.USD","LU1878469433.USD","BK4533","LU0320765489.SGD","PHVS","LU1291159041.SGD","LU1989764664.SGD","LU0476273544.USD","RGTX","LU2242649171.HKD","LU0306807586.USD","BK4121","LU0345769128.USD","LU0823414551.USD","LU0985489474.SGD","LU0225771236.USD","BK4141","LU1720051108.HKD","LU1057294990.SGD","OZEM","BK4588","IE00B7SZL793.SGD","IE0031619046.USD","LU2265009873.SGD","LU2242646821.SGD","WQTM","TBXU","BK4585","LU1989772840.SGD","04332","LU2294711713.HKD","BK4168","IE00B19Z3B42.SGD","LU0234572021.USD","IONQ","LU0957808578.USD","OIH","PJP","LU1894683348.USD","BK4599","CQTM","ROIV","LU1720051017.SGD","SRPT","LU2468319806.SGD","SG9999001176.SGD","LU1983299246.USD","BK4534","LU0077335932.USD","LU0211331839.USD","USNG","BK4102","ALV","IE0009354923.USD","PPH","LU0353189763.USD","CHRW","LU0823416689.USD","RGTU","LU0114720955.EUR","LU0444971666.USD","LU2362540622.SGD","QTUP","LU0011850046.USD","DYN","LU0029874061.USD","LU1791710582.SGD","LU0878866978.SGD","SGML","VTWG","RGTC","IBAT","LU0225283273.USD","LU2087625088.SGD","BK4602","IE00B19Z4B17.USD","BK4578","IOYY","WATS","SEI","LU1153585028.USD","LU2362541513.USD","LU2506952170.USD","BK4581","LU1061106388.HKD","LU2249611893.SGD","LU0170899867.USD","LU0048584097.USD","LU0353189680.USD","BIB","LU0266013472.USD","VCLN","UNFI","LU0882574055.USD","SGXZ57979304.SGD","LU0889565916.HKD","SG9999001440.SGD","LU0289739699.SGD","NTLA","IONL","HYDR","IE00BJJMRZ35.SGD","LU2098885051.SGD","BK4592","IBBQ","LU2491050154.USD","BK4541","SG9999002232.USD","BK4124","IE0009355771.USD","LU2506951958.HKD","BK4597","LU1989772923.USD","LU0238689110.USD","BK4082","LU0985481810.HKD","LU1883839398.USD","LU2506951792.HKD","LU2596442595.SGD","LU0068578508.USD","LU0225284248.USD","MEDX","IE00B4R5TH58.HKD","LU1064131342.USD","LU1791710400.SGD","BEZ","IE00BFTCPJ56.SGD","BK4591","BK4532","LU1804176565.USD","LU2362541273.HKD","RGTZ","LU0950375773.USD","LU1642822529.SGD","LU0432979614.USD","LU2324357040.USD","IE0002270589.USD","SG9999002224.SGD","LU2242652126.USD","BEX","IONX","LU0109394709.USD","LU0528227936.USD","LU2244417387.USD","BBH","IE00BLSP4452.SGD","SG9999003800.SGD","BK4139","LU1894683264.USD","GNOM","BK4568","ILMN","RGTI","BK4170","IE0002141913.USD","RGYY","LU1718418525.SGD","LU1989771016.USD","IBB","SG9999001176.USD","CNRG","LU2089984988.USD","LU0208291251.USD","LU2506951875.HKD","LU1489326972.SGD","ABM","BK4548","SG9999011175.SGD","LU0251132253.USD","LU1815336760.USD","BK4182","GNMX","LU2112291526.USD","LU0823417653.USD","LU1988902786.USD","BK4505","SIMS","LU0823417737.USD","BK4007","BK4535","NVS","LU0321505868.SGD","IE00B2B36J28.USD","IONZ","LU0444973449.USD","LU1093756325.SGD","LU1861558580.USD","SG9999013999.USD","PTH","SRPU","BK4550","IE00B19Z3581.USD","LU0267386448.USD","LU1303367103.USD","ZAP","PFE","IE0034235188.USD","BHVN","LU2506952097.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665802322","title":"Roivant公司實驗性肺部疾病藥物在中期研究中達到預期目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2665802322","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665802322?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 18:59","pubTimestamp":1788865191,"startTime":"0","endTime":"0","summary":"Roivant公司实验性肺部疾病药物在中期研究中达到预期目标路透9月8日-Roivant公司周二表示，其试验性药物在针对一种肺部疾病相关高血压患者的中期研究中达到了主要目标，受此消息提振，该公司股价在盘前交易中上涨约20%。继上月获得美国批准用于治疗皮肤和肌肉疾病的药物Lisraya后，Roivant一直在扩充其后期研发管线。Roivant表示，该公司已启动一项后期临床试验，计划在全球范围内招募约375名患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T4500RV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","BK4007","BK4139","ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192184963","title":"實驗性肺病藥物中期研究達主要終點 Roivant Sciences股價盤前飆升21.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1192184963","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192184963?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 18:11","pubTimestamp":1788862270,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd.股价在盘前交易中大涨21.1%，此前该公司宣布其研发的一款针对肺部疾病的实验性药物，在一项中期研究中成功达到了主要疗效终点。这一积极进展显著提振了市场信心，推动股价迅速走高。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV","BK4139","BK4007","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102884849","title":"Roivant公布Mosliciguat治療間質性肺病相關肺動脈高壓（Ph-Ild）的Phocus研究積極結果，並披露正在進行的Phrontier III期試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1102884849","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102884849?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 18:01","pubTimestamp":1788861671,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd.今日宣布，其针对Mosliciguat在间质性肺病相关肺动脉高压患者中的Phocus研究取得了振奋人心的积极成果。与此同时，该公司还揭开了正在推进的Phrontier III期研究的面纱，这一举措标志着该候选药物在临床开发道路上又迈出了坚实一步。据悉，Phocus研究的数据不仅验证了药物的有效性，还为这一长期缺乏有效疗法的罕见病症带来了新的希望之光。值得注意的是，Phrontier III期研究的启动，无疑将进一步巩固Mosliciguat在该适应症领域的潜在治疗地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","BK4139","ROIV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665332349","title":"邁普醫學：可吸收止血流體明膠作為第三類醫療器械進入臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2665332349","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665332349?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 16:14","pubTimestamp":1788855283,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PSYK","MDEV","AGNG","IBBQ","LGHT","LNGR","RSPH","IEIH","GDOC","HART","BMED","MDTX","PTH","MEDX","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665434161","title":"中信建投：醫療器械業績持續改善 醫療服務收入平穩增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2665434161","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665434161?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 10:56","pubTimestamp":1788836160,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中信建投发布研报称，医疗器械板块Q2收入延续增长趋势，单季度利润增速四年来首次转正。IVD：26Q2 IVD板块收入在过去两年来首次恢复正增长，利润端大幅增长。从收入端来看，二季度板块收入仍保持正增长，其中眼科医疗服务公司2025Q2低基数相对较低，但板块今年二季度收入增速相较一季度的增速有所降低，表明消费环境压力仍然存在。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","MEDX","IEIH","BK1574","601066","RSPH","09996","MDEV","AGNG","HART","BK0276","BK1100","GDOC","LGHT","PTH","LNGR","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665231964","title":"三諾生物：取得醫療器械註冊證及註冊變更文件","url":"https://stock-news.laohu8.com/highlight/detail?id=2665231964","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665231964?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 19:24","pubTimestamp":1788780275,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GDOC","LGHT","LNGR","RSPH","MEDX","IEIH","HART","MDEV","AGNG","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665315638","title":"安圖生物：公司及子公司獲得四項醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2665315638","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665315638?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:03","pubTimestamp":1788775426,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PTH","AGNG","GDOC","IEIH","LNGR","RSPH","HART","MEDX","MDEV","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665945893","title":"麥科田（2041.HK）登陸港交所，平台型醫療器械龍頭起航","url":"https://stock-news.laohu8.com/highlight/detail?id=2665945893","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665945893?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:10","pubTimestamp":1788761405,"startTime":"0","endTime":"0","summary":"麦科田通过多赛道布局、全球化运营、持续并购整合，构建一个抗周期、可持续的医疗器械平台。","market":"sg","thumbnail":"https://img2.gelonghui.com/52490-957b9937-e172-429c-8c01-0917b7b8c624.jpg?guru_height=2666&guru_width=4000&guru_size=1163899","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/52490-957b9937-e172-429c-8c01-0917b7b8c624.jpg?guru_height=2666&guru_width=4000&guru_size=1163899"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6537932","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LNGR","HEXmain","PTH","LGHT","BK1583","02041","GDOC","MDEV","BK1100","HART","159883","09996","MEDX","BK1574","AGNG","IEIH","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399937","title":"山東省寧陽縣市場監管局開展醫療器械專項現場檢查","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399937","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665399937?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 12:37","pubTimestamp":1788755820,"startTime":"0","endTime":"0","summary":"中国质量新闻网讯 9月7日，山东省宁阳县市场监管局执法人员深入辖区零售药店，开展医疗器械专项现场检查。执法人员重点查看血压计等二类医疗器械，仔细核对产品注册资料、进货票据，查验产品有效期、包装标识，排查有无过期失效、来路不明产品等风险隐患。检查过程坚持监管和指导同步开展，现场向药店从业人员讲解医疗器械经营相关规定，指出经营中的不足，督促经营者落实主体责任，规范进货查验和日常自查工作。下一步，该局将持续加大医疗器械监管频次，紧盯零售药店经营风险，切实保障群众用械安全。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-07/doc-iniqykzy9680694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","MEDX","RSPH","GDOC","PTH","LNGR","BK1583","BK1100","09996","159883","HART","LGHT","AGNG","MDEV","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399350","title":"又一家醫療器械企業登陸港股，麥科田(02041)「含金量」幾何？","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399350","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665399350?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 12:07","pubTimestamp":1788754034,"startTime":"0","endTime":"0","summary":"随着多家医疗器械企业中报密集披露，医疗器械板块整体修复态势明确，业绩端已出现向上拐点。9月7日，麦科田正式于港交所挂牌上市，这意味着港股医疗器械板块再添一家平台型龙头。据多家权威机构测算，2026年全球医疗器械市场规模预计在6000亿至8000亿美元之间，并有望于2035年突破万亿美元大关。整体来看，麦科田此次登陆港股，业绩方面盈利拐点已经确认，商业化路径成熟，平台型的全面产品组合和全","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492650.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MDEV","AGNG","BK1583","BK1100","KCAI","RSPH","159883","MEDX","VXUS","PTH","GDOC","LNGR","02041","BK4588","LGHT","HART","IEIH","BK4585","BK1574","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665968913","title":"高瓴重倉的醫療器械公司，IPO首日開盤跌超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665968913","media":"直通IPO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665968913?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 11:01","pubTimestamp":1788750084,"startTime":"0","endTime":"0","summary":"然而，这家被高瓴资本重仓押注的企业，并未迎来开门红。上市首日，麦科田开盘即破发，股价报10港元/股，较发行价15.43港元大跌35.15%，总市值定格在53.86亿。值得注意的是，此次IPO未引入基石投资者。截至2026年3月31日，公司拥有320余款商业化医疗器械产品及60余款在研产品，覆盖全球逾140个国家及地区，经销商网络由2000余家经销商组成。尽管拥有强大的产业背景、稳健的基本面和明星机构背书，麦科田上市首日的股价表现依然不尽如人意。","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/09/07110158370392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GDOC","LNGR","IEIH","REDS","BK1574","MEDX","MDEV","BK1583","BK4127","PTH","RSPH","159883","FRHC","AGNG","09996","HART","KCE","LGHT","IPOS","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665250366","title":"海南出台醫療器械委託生產監管新政","url":"https://stock-news.laohu8.com/highlight/detail?id=2665250366","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665250366?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 07:43","pubTimestamp":1788651815,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IEIH","AGNG","RSPH","LGHT","GDOC","LNGR","MEDX","HART","PTH","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665350040","title":"格式塔創始人彭雷：三到五年內，腦機接口本質上是嚴肅的醫療器械","url":"https://stock-news.laohu8.com/highlight/detail?id=2665350040","media":"睿见Economy","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665350040?lang=zh_tw&edition=fundamental","pubTime":"2026-09-05 14:01","pubTimestamp":1788588060,"startTime":"0","endTime":"0","summary":"格式塔创始人、CEO彭雷表示，脑机接口赛道要解决的核心问题就一个：持续提高对脑内读写的分辨率。在他看来，至少在看得见的三到五年内，脑机接口本质上还是严肃的医疗器械，它的创新落地，付费方一定是医疗体系与患者。他指出，如何依托我国特色的医疗保障体系，让前沿的脑机接口应用纳入医保，惠及更多患者、解决实际病痛，这就是付费层面需要思考的问题。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/hy/hyjz/2026-09-05/doc-iniquccw0443893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["GDOC","HART","IBRN","MDEV","LNGR","BK1583","MEDX","BK1100","AGNG","IEIH","MNTL","BK1574","LGHT","PTH","159883","RSPH","09996"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}